🇺🇸 FDA

Intelligence Platform

Patents

Browse 783 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8980952

Methods for treating brain swelling with a compound that blocks a non-selective cation cha

The United States of America as Represented by the Dept. of Veterans Affairs · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8961955

Maintenance and propagation of mesenchymal stem cells

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIR · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8961989

Methods for producing an immune response to tuberculosis

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8957015

Tumor suppressor gene p47ING3

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8940535

Stem cell culture medium and method of using said medium and the cells

The United States of America as Represented by the Dept. of Veterans Affairs · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8940700

E-selectin compositions and use thereof for inducing E-selectin tolerance

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8926986

Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8927030

Use of nitrite salts for the treatment of cardiovascular conditions

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8926987

Replication-competent adenoviral vectors

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8921071

Targeting poly-gamma-glutamic acid to treat Staphylococcus epidermidis and related infecti

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8911728

High-affinity fully functional soluble single-domain human CD4, antibodies, and related fu

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8911742

Transcutaneous immunization without heterologous adjuvant

The United States of America as represented by the Secretary of the Army · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8906358

Leishmania challenge model

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8901093

Custom vectors for treating and preventing pancreatic cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8895018

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric imp

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8895521

Methods and compositions for the treatment of uveitis

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8877199

B cell surface reactive antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8877213

Live attenuated Leishmania vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8877765

Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8871191

Use of IL-15 preparations to treat lymphopenia

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865880

Identification of a novel BHD gene

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865686

Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8858946

Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8858930

Live attenuated bacterial vaccine to reduce or inhibit carriage and shedding of enterohemo

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted